This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Waldemar Kolanus: Innovator in Pharmaceutical Composition
Introduction
Waldemar Kolanus is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating autoimmune and tumoral diseases.
Latest Patents
Kolanus holds a patent for "Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors." This invention relates to a pharmaceutical composition that includes compounds selected from specific general formulas and their enantiomers, diastereomers, or pharmaceutically acceptable salts. The composition is designed for use in treating autoimmune and tumoral diseases, as well as for immunosuppression.
Career Highlights
Waldemar Kolanus is affiliated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where he has been involved in research and development in the pharmaceutical sector. His work has led to advancements in therapeutic options for patients suffering from complex diseases.
Collaborations
Kolanus has collaborated with esteemed colleagues such as Michael Famulok and Barbara Tappertzhofen, contributing to a rich environment of innovation and research.
Conclusion
Waldemar Kolanus stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative treatments for serious health conditions. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile